Hofmann, F;Biel, M;Kaupp, UBInternational Union of Pharmacology. LI. Nomenclature and structure-function relationships of cyclic nucleotide-regulated channels.Pharmacol Rev2005574455-62
Feil, S;Zimmermann, P;Knorn, A;Brummer, S;Schlossmann, J;Hofmann, F;Feil, RDistribution of cGMP-dependent protein kinase type I and its isoforms in the mouse brain and retina.Neuroscience20051353863-8
Demyanenko, GP;Halberstadt, AI;Pryzwansky, KB;Werner, C;Hofmann, F;Maness, PFAbnormal neocortical development in mice lacking cGMP-dependent protein kinase I.Brain Res Dev Brain Res200516011-8
Bijvelds, MJ;Jorna, H;Verkade, HJ;Bot, AG;Hofmann, F;Agellon, LB;Sinaasappel, M;de Jonge, HRActivation of CFTR by ASBT-mediated bile salt absorption.Am J Physiol Gastrointest Liver Physiol20052895G870-9
Hofmann, FThe biology of cyclic GMP-dependent protein kinases.J Biol Chem200528011-4
Werner, CG;Godfrey, V;Arnold, RR;Featherstone, GL;Bender, D;Schlossmann, J;Schiemann, M;Hofmann, F;Pryzwansky, KBNeutrophil dysfunction in guanosine 3',5'-cyclic monophosphate-dependent protein kinase I-deficient mice.J Immunol200517531919-29
Welling, A;Hofmann, F;Wegener, JWInhibition of L-type Cav1.2 Ca2+ channels by 2,(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) and 2-[1-(3-dimethyl-aminopropyl)-5-methoxyindol-3-yl]-3-(1H-indol-3-yl) maleimide (Go6983).Mol Pharmacol2005672541-4
Schlossmann, J;Hofmann, FcGMP-dependent protein kinases in drug discovery.Drug Discov Today2005109627-34
Schlossmann, J;Feil, R;Hofmann, FInsights into cGMP signalling derived from cGMP kinase knockout mice.Front Biosci2005101279-89
Sausbier, M;Arntz, C;Bucurenciu, I;Zhao, H;Zhou, XB;Sausbier, U;Feil, S;Kamm, S;Essin, K;Sailer, CA;Abdullah, U;Krippeit-Drews, P;Feil, R;Hofmann, F;Knaus, HG;Kenyon, C;Shipston, MJ;Storm, JF;Neuhuber, W;Korth, M;Schubert, R;Gollasch, M;Ruth, PElevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation in BK channel-deficient mice.Circulation2005112160-8
Login
